Eric Donahue
Hospitalist · Nampa, IDNPI 1831624691
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 31.0% of the total. Reporting peaked in 2022 at $188 and has fallen 56.2% since, to $82 in 2025. Among hospitalist clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$160
- Shield Therapeutics Inc$48
- Organon$47
- Pfizer$44
- Novo Nordisk$39
- Exact Sciences$35
- plus $142 from 7 others
What the payments were for
- Food & beverage$515100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $160 |
| Shield Therapeutics Inc | 2 | $48 |
| Organon | 2 | $47 |
| Pfizer | 2 | $44 |
| Novo Nordisk | 2 | $39 |
| Exact Sciences | 2 | $35 |
| Bayer | 2 | $33 |
| Myovant Sciences Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Biogen | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $13 |
How this compares
$515 in reported general payments places this provider in the 95th percentile of 102 hospitalist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 69 | $626 |
| Atorvastatin Calcium | 61 | $496 |
| Gabapentin | 34 | $454 |
| Losartan Potassium | 44 | $285 |
| Hydroxyzine Hcl | 21 | $242 |
| Rosuvastatin Calcium | 23 | $234 |
| Lisinopril | 29 | $229 |
| Buspirone Hcl | 16 | $195 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $123 |
| Metoprolol Succinate | 11 | $95 |
| Sertraline Hcl | 12 | $63 |
| Meloxicam | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Nampa
- Kristen DaltonNampa$115
- Daniel CooperNampa$104
- Blythe BartosNampa$103
- Leah BlakeNampa$39
- Stefani WesterbergBoise$959
- Sean UrquhartLewiston$702
- Kyle WongTwin Falls$614
- Praveen BereBoise$571
- Neil IbrahimCoeur D Alene$498
- Julie MeltzerCoeur D Alene$361
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.